Open Accessibility Menu

Hidradenitis Suppurativa Clinic

Skilled Rheumatologists in Washington DC

Hidradenitis suppurativa (HS) is a common chronic, recurrent inflammatory disease of the apocrine sweat glands. Patients with HS develop debilitating, recurrent, inflammatory nodules, sinus tracts and abscesses in the underarms, breasts, groin, and buttocks.

HS is common and affects more than one percent of the population. Women are three times more commonly affected than men, and the disease is more common in African Americans than Caucasians. Smoking and obesity are strongly correlated with disease activity.

Get the Care You Need from Knowledgeable Professionals

Patients with HS often have trouble finding doctors who recognize this disease. Some patients report that it takes years to make the diagnosis and others describe trips to many doctors before they can get help for their condition.

At The GW Medical Faculty Associates, we are committed to treating patients with HS and we have developed a multidisciplinary team to focus on coordinated care. Led by Victoria Shanmugam, MD, our team of dedicated professionals provide coordinated care for HS patients that is focused on improving symptoms and controlling disease activity.

If you think you have HS:

  • Stop smoking: HS activity is very strongly associated with smoking
  • Try to lose weight
  • Talk to your doctor about a referral to the GW Hidradenitis Suppurativa Team. Call 202.741.2488 for an appointment.

Our Team of HS Specialists:

Clinical Trials

  • Wound Etiology and Healing Study (WE-HEAL)
    The purpose of the WE-HEAL Study is to help researchers use human tissue samples and health records to study the reasons why some patients heal quickly and some have problems healing wounds. All patients seen with an open wound and Hidradenitis suppurativa are asked to participate. Information from this research may help to understand how to prevent and treat certain diseases.
  • STOP Scleroderma
    The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.